Article Versions Notes

Canosa A, Calvo A, Mora G, Moglia C, Brunetti M, Barberis M, Borghero G, Caponnetto C, Trojsi F, Spataro R, et al. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations. Biomedicines. 2023; 11(3):704. https://doi.org/10.3390/biomedicines11030704

Canosa, Antonio, Andrea Calvo, Gabriele Mora, Cristina Moglia, Maura Brunetti, Marco Barberis, Giuseppe Borghero, Claudia Caponnetto, Francesca Trojsi, Rossella Spataro, and et al. 2023. "The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations" Biomedicines 11, no. 3: 704. https://doi.org/10.3390/biomedicines11030704

Canosa, A., Calvo, A., Mora, G., Moglia, C., Brunetti, M., Barberis, M., Borghero, G., Caponnetto, C., Trojsi, F., Spataro, R., Volanti, P., Simone, I. L., Salvi, F., Logullo, F. O., Riva, N., Tremolizzo, L., Giannini, F., Mandrioli, J., Tanel, R., ... on behalf of ITALSGEN Consortium. (2023). The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations. Biomedicines, 11(3), 704. https://doi.org/10.3390/biomedicines11030704